-
Study aim
-
Investigating the effect of probiotic supplementation on the change of intestinal microflora
-
Design
-
This study is a Triple-blind Randomized Controlled Clinical Trial with a parallel group design of 50 patients. A simple method has been used for randomization. Randomization unit is Individual. Excel software has been used for randomization. The central service method was used for allocation concealment.
-
Settings and conduct
-
The intervention site is Clinic of National Nutrition Research Institute.
Study participants, main study researchers, intervention and treatment partners, data collectors, and data analyzers were blinded in this study, and someone outside the study was used for randomization and labeling of probiotic and placebo supplements.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Age18-50 years, weight regain after bariatric surgery
, food addiction
Exclusion criteria:
Pregnancy, lactation, use of any antibiotics, probiotic product or protein supplement, liver disease, kidney, cancer and thyroid disease, use of weight loss and appetite suppressants
-
Intervention groups
-
Intervention group: for 12 weeks, 2 Multi-strain probiotic capsules daily (after breakfast and after lunch) with hypocaloric (-300 to 500 kcal/day), high-protein (25% of energy) diet and ten sessions (Once a week individually) of cognitive behavioral therapy (CBT) intervention (online based).
Control group: for 12 weeks, 2 placebo capsules daily (after breakfast and after lunch) with hypocaloric (-300 to 500 kcal/day), high-protein (25% of energy) diet and ten sessions (Once a week individually) of cognitive behavioral therapy (CBT) intervention (online based).
Supplements are provided by Tekgen Zist company.
-
Main outcome variables
-
Abundance of Eubacterium ؛ Akkermansia ؛ Megamonas ؛ Bifidobacterium ؛ Lactobacillus ؛ Bacteroides